Author:
Wang Wei,Yin Linliang,Gonzalez-Malerva Laura,Wang Shaopeng,Yu Xiaobo,Eaton Seron,Zhang Shengtao,Chen Hong-Yuan,LaBaer Joshua,Tao Nongjian
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Ehrlich, P. Address in pathology on chemotherapeutics: Scientific principles, methods and results. Lancet 2, 445–451 (1913).
2. Adams, G. P. & Weiner, L. M. Monoclonal antibody therapy of cancer. Nature Biotechnol. 23, 1147–1157 (2005).
3. Copeland, R. A., Pompliano, D. L. & Meek, T. D. Opinion - Drug-target residence time and its implications for lead optimization. Nature Rev. Drug Disc. 5, 730–739 (2006).
4. Swinney, D. C. The role of binding kinetics in therapeutically useful drug action. Curr. Opin. Drug Disc. Develop. 12, 31–39 (2009).
5. Nahta, R., Yu, D. H., Hung, M. C., Hortobagyi, G. N. & Esteva, F. J. Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nature Clin. Pract. Oncol. 3, 269–280 (2006).
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献